DEA Judge Orders Transcript Corrections in Cannabis Rescheduling Case

Transcript Corrections Ordered Mid-Proceeding

ALJ John Mulrooney directed parties to submit corrections to the official rescheduling hearing transcript, signaling procedural care in a case with sweeping regulatory stakes. The order follows multi-day evidentiary hearings held earlier this year in the DEA's administrative review of the proposed rescheduling action initiated by the Department of Health and Human Services in August 2023.

Transcript accuracy matters in administrative law. The official record forms the evidentiary basis for the ALJ's recommended decision to the DEA Administrator, who retains final authority under 21 U.S.C. § 811(a) to reschedule controlled substances.

Rescheduling Review Remains in Administrative Phase

The DEA's formal rescheduling proceeding, launched after HHS recommended moving cannabis to Schedule III, is still in the evidentiary phase with no final timeline disclosed. The agency published a Notice of Proposed Rulemaking in May 2024. That triggered the Administrative Procedure Act's notice-and-comment process and subsequent request for a formal hearing.

More than 43,000 public comments were filed during the initial comment period. Dozens of parties—including state regulators, medical researchers, and industry stakeholders—requested participant status in the formal hearing process.

What Transcript Errors Mean for the Record

Correcting hearing transcripts is standard administrative practice, but the timing suggests the proceeding is advancing toward the briefing or initial-decision stage. Parties typically review transcripts for errors in witness testimony, exhibit references, or procedural exchanges that could affect appellate review or the ALJ's findings of fact.

The DEA hasn't disclosed the nature or scope of the errors flagged in Mulrooney's order. Corrections are typically ministerial—fixing misheard words, clarifying exhibit numbers, or adjusting punctuation that alters meaning.

Schedule III Would Eliminate 280E Tax Penalty

If the DEA finalizes the rescheduling, state-licensed cannabis businesses would immediately gain access to federal tax deductions under 26 U.S.C. § 280E. That provision currently bars Schedule I operators from deducting ordinary business expenses. Industry analysts estimate the change would reduce effective tax rates for multi-state operators by 20 to 40 percentage points, freeing billions in annual cash flow.

Rescheduling wouldn't legalize cannabis federally. It wouldn't resolve the conflict between state programs and the Controlled Substances Act, either. Schedule III substances remain federally controlled and subject to DEA manufacturing quotas, FDA approval pathways, and criminal penalties for unauthorized distribution.

Political and Legal Variables Still in Play

The rescheduling timeline is subject to executive branch priorities, judicial challenges, and the outcome of the 2026 midterm elections. A change in DEA leadership or White House policy could alter the agency's posture—any final rule will face legal challenges from opponents who argue cannabis meets Schedule I criteria or from reform advocates who say Schedule III doesn't go far enough.

The Congressional Review Act gives lawmakers 60 legislative days to overturn a final rule by joint resolution. That window opens only after the DEA publishes a final rule in the Federal Register.

What Happens Next in the Administrative Process

After transcript corrections are finalized, the proceeding moves to post-hearing briefs, followed by ALJ Mulrooney's recommended decision to the DEA Administrator. The Administrator isn't bound by the ALJ's recommendation but must issue a final decision based on the administrative record.

No deadline has been set for the recommended decision. Administrative rescheduling proceedings have historically taken years—the last completed rescheduling petition for cannabis, filed in 2011, was denied in 2016 after a five-year review.

For full background on this story, see the CannIntel topic hub on DEA rescheduling. The next procedural signal will be the filing of corrected transcripts or the issuance of a briefing schedule.